HBZ
gene geneOn this page
Also known as HBZ1HBZ-T1
Summary
HBZ (hemoglobin subunit zeta, HGNC:4835) is a protein-coding gene on chromosome 16p13.3, encoding Hemoglobin subunit zeta (P02008). The zeta chain is an alpha-type chain of mammalian embryonic hemoglobin.
Zeta-globin is an alpha-like hemoglobin. The zeta-globin polypeptide is synthesized in the yolk sac of the early embryo, while alpha-globin is produced throughout fetal and adult life. The zeta-globin gene is a member of the human alpha-globin gene cluster that includes five functional genes and two pseudogenes. The order of genes is: 5’ - zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 -alpha-1 - theta1 - 3'.
Source: NCBI Gene 3050 — RefSeq curated summary.
At a glance
- GWAS associations: 14
- Clinical variants (ClinVar): 18 total
- Druggable target: yes
- MANE Select transcript:
NM_005332
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4835 |
| Approved symbol | HBZ |
| Name | hemoglobin subunit zeta |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HBZ1, HBZ-T1 |
| Ensembl gene | ENSG00000130656 |
| Ensembl biotype | protein_coding |
| OMIM | 142310 |
| Entrez | 3050 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000252951, ENST00000652335
RefSeq mRNA: 1 — MANE Select: NM_005332
NM_005332
CCDS: CCDS10397
Canonical transcript exons
ENST00000252951 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001143658 | 154272 | 154503 |
| ENSE00001143667 | 152644 | 153004 |
| ENSE00003606697 | 153892 | 154096 |
Expression profiles
Bgee: expression breadth ubiquitous, 117 present calls, max score 87.10.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 4.9859 / max 713.1711, expressed in 97 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 151855 | 2.4859 | 79 |
| 151857 | 1.9685 | 76 |
| 151856 | 0.3055 | 62 |
| 151854 | 0.1999 | 48 |
| 151852 | 0.0131 | 3 |
| 151851 | 0.0129 | 4 |
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.10 | silver quality |
| left testis | UBERON:0004533 | 78.44 | gold quality |
| right testis | UBERON:0004534 | 78.25 | gold quality |
| testis | UBERON:0000473 | 77.59 | gold quality |
| blood | UBERON:0000178 | 74.46 | gold quality |
| ganglionic eminence | UBERON:0004023 | 65.31 | gold quality |
| bone marrow | UBERON:0002371 | 63.60 | gold quality |
| bone marrow cell | CL:0002092 | 59.32 | silver quality |
| adrenal tissue | UBERON:0018303 | 58.23 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 55.24 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 54.73 | gold quality |
| amygdala | UBERON:0001876 | 54.72 | gold quality |
| temporal lobe | UBERON:0001871 | 54.71 | gold quality |
| ectocervix | UBERON:0012249 | 54.14 | gold quality |
| placenta | UBERON:0001987 | 53.76 | gold quality |
| monocyte | CL:0000576 | 53.52 | gold quality |
| nucleus accumbens | UBERON:0001882 | 53.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 53.09 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 52.53 | gold quality |
| Ammon’s horn | UBERON:0001954 | 52.12 | gold quality |
| leukocyte | CL:0000738 | 51.89 | gold quality |
| cortical plate | UBERON:0005343 | 51.59 | gold quality |
| cerebral cortex | UBERON:0000956 | 51.17 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.04 | gold quality |
| skin of leg | UBERON:0001511 | 50.88 | gold quality |
| primary visual cortex | UBERON:0002436 | 50.83 | gold quality |
| right lung | UBERON:0002167 | 50.40 | gold quality |
| adipose tissue | UBERON:0001013 | 50.25 | gold quality |
| frontal cortex | UBERON:0001870 | 50.20 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 49.68 | gold quality |
Single-cell (SCXA)
Detected in 11 experiment(s), a significant marker in 10.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7407 | yes | 208381.29 |
| E-CURD-98 | yes | 175477.97 |
| E-HCAD-24 | yes | 155061.76 |
| E-HCAD-56 | yes | 79912.52 |
| E-MTAB-8205 | yes | 13669.02 |
| E-ANND-5 | yes | 1060.67 |
| E-MTAB-10042 | yes | 43.09 |
| E-MTAB-9388 | yes | 9.31 |
| E-MTAB-9067 | yes | 6.46 |
| E-HCAD-10 | yes | 5.83 |
| E-ANND-3 | no | 1.08 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): BCL11A, GATA1, JUN, JUND, RREB1, RUNX1, SP1, ZNF274
miRNA regulators (miRDB)
1 targeting HBZ, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29B-2-5P | 99.67 | 68.98 | 1726 |
Literature-anchored findings (GeneRIF, showing 4)
- Chimeric zeta globin exhibits oxygen binding characteristics which fall within the range observed in adult human and human embryonic hemoglobins. (PMID:11747442)
- Hb zeta(2)beta(2)(S) exhibits an O(2) affinity as well as a Hill coefficient, Bohr response, and allosteric properties in vitro that are suboptimally suited for physiological O(2) transport in vivo (PMID:15555579)
- Data indicate a tetranucleotide 3’UTR motif that is required for the high-level accumulation of zeta-globin transcripts in cultured cells, and demonstrate that it prolongs their cytoplasmic half-lives. (PMID:24751163)
- Assessment of Bcl-xL, TAX, and HBZ Gene Expression in Adult T cell Leukemia/Lymphoma Patients. (PMID:37565279)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Hba-x | ENSMUSG00000055609 |
| rattus_norvegicus | Hbz | ENSRNOG00000020536 |
| drosophila_melanogaster | glob1 | FBGN0027657 |
| caenorhabditis_elegans | WBGENE00008996 | |
| caenorhabditis_elegans | WBGENE00077763 |
Paralogs (11): HBQ1 (ENSG00000086506), CYGB (ENSG00000161544), HBA2 (ENSG00000188536), HBG2 (ENSG00000196565), MB (ENSG00000198125), HBA1 (ENSG00000206172), HBM (ENSG00000206177), HBE1 (ENSG00000213931), HBG1 (ENSG00000213934), HBD (ENSG00000223609), HBB (ENSG00000244734)
Protein
Protein identifiers
Hemoglobin subunit zeta — P02008 (reviewed: P02008)
Alternative names: HBAZ, Hemoglobin zeta chain, Zeta-globin
All UniProt accessions (2): P02008, A0A494C057
UniProt curated annotations — full annotation on UniProt →
Function. The zeta chain is an alpha-type chain of mammalian embryonic hemoglobin.
Subunit / interactions. Heterotetramer of two zeta chains and two epsilon chains in early embryonic hemoglobin Gower-1; two zeta chains and two gamma chains in fetal hemoglobin Portland-1. Heterotetramer of two zeta chains and two beta chains in hemoglobin Portland-2, detected in fetuses and neonates with homozygous alpha-thalassemia.
Tissue specificity. Detected in fetal erythrocytes (at protein level).
Similarity. Belongs to the globin family.
RefSeq proteins (1): NP_005323* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000971 | Globin | Domain |
| IPR002338 | Hemoglobin_a-typ | Family |
| IPR002340 | Hemoglobin_zeta | Family |
| IPR009050 | Globin-like_sf | Homologous_superfamily |
| IPR012292 | Globin/Proto | Homologous_superfamily |
| IPR050056 | Hemoglobin_oxygen_transport | Family |
Pfam: PF00042
UniProt features (22 total): helix 10, modified residue 5, turn 2, binding site 2, initiator methionine 1, chain 1, domain 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 3W4U | X-RAY DIFFRACTION | 1.95 |
| 1JEB | X-RAY DIFFRACTION | 2.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P02008-F1 | 97.89 | 0.99 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2): 59 (distal binding residue); 88 (proximal binding residue)
Post-translational modifications (5): 2, 29, 53, 73, 82
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 98 (showing top):
GOBP_MYELOID_CELL_DIFFERENTIATION, GOBP_MYELOID_CELL_HOMEOSTASIS, GOBP_MYELOID_CELL_DEVELOPMENT, GOBP_ERYTHROCYTE_HOMEOSTASIS, ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN, BROWNE_HCMV_INFECTION_48HR_DN, GATA3_01, GOBP_ONE_CARBON_COMPOUND_TRANSPORT, GOBP_GAS_TRANSPORT, GOBP_OXYGEN_TRANSPORT, GATA1_04, WELCH_GATA1_TARGETS, MODULE_88, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS, GATA1_02
GO Biological Process (5): negative regulation of transcription by RNA polymerase II (GO:0000122), carbon dioxide transport (GO:0015670), oxygen transport (GO:0015671), erythrocyte maturation (GO:0043249), erythrocyte development (GO:0048821)
GO Molecular Function (6): oxygen carrier activity (GO:0005344), iron ion binding (GO:0005506), oxygen binding (GO:0019825), heme binding (GO:0020037), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (3): hemoglobin complex (GO:0005833), haptoglobin-hemoglobin complex (GO:0031838), extracellular exosome (GO:0070062)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| gas transport | 2 |
| protein-containing complex | 2 |
| regulation of transcription by RNA polymerase II | 1 |
| transcription by RNA polymerase II | 1 |
| negative regulation of DNA-templated transcription | 1 |
| one-carbon compound transport | 1 |
| cell maturation | 1 |
| erythrocyte development | 1 |
| erythrocyte differentiation | 1 |
| myeloid cell development | 1 |
| oxygen transport | 1 |
| oxygen binding | 1 |
| molecular carrier activity | 1 |
| transition metal ion binding | 1 |
| small molecule binding | 1 |
| tetrapyrrole binding | 1 |
| binding | 1 |
| cation binding | 1 |
| cytosol | 1 |
| extracellular vesicle | 1 |
Protein interactions and networks
STRING
1058 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| HBZ | SMAD2 | Q15796 | 909 |
| HBZ | JUND | P17535 | 886 |
| HBZ | JUN | P05412 | 879 |
| HBZ | EP300 | Q09472 | 860 |
| HBZ | CREB1 | P16220 | 814 |
| HBZ | MPG | P29372 | 768 |
| HBZ | CREM | Q03060 | 758 |
| HBZ | KLF1 | Q13351 | 728 |
| HBZ | CENPV | Q7Z7K6 | 720 |
| HBZ | FOXP3 | Q9BZS1 | 624 |
| HBZ | SMAD3 | P84022 | 619 |
| HBZ | PPP1R15A | O75807 | 603 |
| HBZ | HBE1 | P02100 | 594 |
| HBZ | ATF3 | P18847 | 581 |
| HBZ | SOCS2 | O14508 | 570 |
IntAct
108 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HBZ | HBB | psi-mi:“MI:0915”(physical association) | 0.860 |
| HBB | HBZ | psi-mi:“MI:0915”(physical association) | 0.860 |
| HBB | HBZ | psi-mi:“MI:0407”(direct interaction) | 0.860 |
| HBZ | HBD | psi-mi:“MI:0915”(physical association) | 0.720 |
| HBZ | HBE1 | psi-mi:“MI:0915”(physical association) | 0.680 |
| HBE1 | HBZ | psi-mi:“MI:0407”(direct interaction) | 0.680 |
| HBZ | KHDRBS2 | psi-mi:“MI:0915”(physical association) | 0.670 |
| HBZ | NOTCH2NLA | psi-mi:“MI:0915”(physical association) | 0.670 |
| KHDRBS2 | HBZ | psi-mi:“MI:0915”(physical association) | 0.670 |
| HBZ | psi-mi:“MI:0915”(physical association) | 0.560 | |
| KRTAP10-7 | HBZ | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | HBZ | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | HBZ | psi-mi:“MI:0915”(physical association) | 0.560 |
| HBZ | DOCK8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HBZ | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HBZ | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HBZ | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (58): HBZ (Two-hybrid), DOCK8 (Two-hybrid), KRT40 (Two-hybrid), KHDRBS2 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-3 (Two-hybrid), NOTCH2NL (Two-hybrid), HBZ (Affinity Capture-MS), SIRT5 (Affinity Capture-MS), HBZ (Affinity Capture-MS), HBZ (Affinity Capture-MS), MYO18A (Affinity Capture-MS), CUL1 (Affinity Capture-Western), HBZ (Affinity Capture-MS)
ESM2 similar proteins: A2XE98, C0HJT7, I1LJI1, I3SPW2, K7N5M6, O04985, O04986, O13163, O13164, O24520, O93348, P02008, P02140, P02141, P06347, P07803, P13786, P23018, P23244, P45721, P45722, P68168, P68169, P80727, P82345, P83272, P83273, P83614, P83625, P84652, P85082, Q3C1F3, Q3C1F4, Q42785, Q42831, Q575S8, Q575S9, Q90485, Q90486, Q91473
Diamond homologs: A1A4Q3, B3EWD1, B3EWE1, B3EWE3, O12985, P01942, P01943, P01944, P01945, P01946, P01947, P01950, P01964, P01967, P01975, P01977, P01978, P01979, P01980, P01983, P01990, P01993, P02001, P02002, P02003, P02005, P02006, P02007, P02008, P02009, P02011, P04237, P04238, P04239, P04240, P04241, P04242, P04243, P04442, P06347
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 51 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| oxygen transport | 6 | 143.6× | 6e-10 |
| erythrocyte development | 6 | 71.8× | 3e-08 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 15 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
237 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:153002:GAG:G | donor_gain | 1.0000 |
| 16:153005:GT:G | donor_loss | 1.0000 |
| 16:153006:T:G | donor_loss | 1.0000 |
| 16:153888:CCAG:C | acceptor_loss | 1.0000 |
| 16:153890:A:AG | acceptor_gain | 1.0000 |
| 16:153890:A:T | acceptor_loss | 1.0000 |
| 16:153891:G:GG | acceptor_gain | 1.0000 |
| 16:153891:GGCT:G | acceptor_gain | 1.0000 |
| 16:153891:GGCTC:G | acceptor_gain | 1.0000 |
| 16:153945:ACCCG:A | acceptor_gain | 1.0000 |
| 16:154093:CAAG:C | donor_loss | 1.0000 |
| 16:154094:AAGG:A | donor_loss | 1.0000 |
| 16:154095:AG:A | donor_gain | 1.0000 |
| 16:154095:AGGT:A | donor_loss | 1.0000 |
| 16:154096:GG:G | donor_gain | 1.0000 |
| 16:154097:GTGC:G | donor_loss | 1.0000 |
| 16:153000:GAGAG:G | donor_gain | 0.9900 |
| 16:153005:G:GG | donor_gain | 0.9900 |
| 16:153890:AG:A | acceptor_gain | 0.9900 |
| 16:153891:GG:G | acceptor_gain | 0.9900 |
| 16:153891:GGC:G | acceptor_gain | 0.9900 |
| 16:153945:ACCC:A | acceptor_gain | 0.9900 |
| 16:154097:G:GG | donor_gain | 0.9900 |
| 16:154270:A:AG | acceptor_gain | 0.9900 |
| 16:154271:G:GG | acceptor_gain | 0.9900 |
| 16:154266:CCCCA:C | acceptor_loss | 0.9800 |
| 16:154267:CCCAG:C | acceptor_loss | 0.9800 |
| 16:154268:CCAG:C | acceptor_loss | 0.9800 |
| 16:154269:CAGC:C | acceptor_loss | 0.9800 |
| 16:154271:GCTC:G | acceptor_gain | 0.9800 |
AlphaMissense
917 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:154091:T:C | F99L | 0.994 |
| 16:154093:C:A | F99L | 0.994 |
| 16:154093:C:G | F99L | 0.994 |
| 16:153926:T:C | F44L | 0.991 |
| 16:153928:C:A | F44L | 0.991 |
| 16:153928:C:G | F44L | 0.991 |
| 16:154058:C:G | H88D | 0.988 |
| 16:154062:C:A | A89D | 0.988 |
| 16:154347:T:A | W126R | 0.985 |
| 16:154347:T:C | W126R | 0.985 |
| 16:152986:G:A | G26D | 0.983 |
| 16:154005:C:A | A70E | 0.983 |
| 16:153975:G:A | G60D | 0.982 |
| 16:153927:T:C | F44S | 0.981 |
| 16:154058:C:A | H88N | 0.981 |
| 16:154092:T:C | F99S | 0.981 |
| 16:154060:C:A | H88Q | 0.980 |
| 16:154060:C:G | H88Q | 0.980 |
| 16:154090:C:A | N98K | 0.980 |
| 16:154090:C:G | N98K | 0.980 |
| 16:154395:C:A | R142S | 0.978 |
| 16:154004:G:C | A70P | 0.977 |
| 16:153927:T:G | F44C | 0.976 |
| 16:154392:T:C | Y141H | 0.976 |
| 16:154080:A:G | D95G | 0.974 |
| 16:154092:T:G | F99C | 0.973 |
| 16:154074:G:C | R93P | 0.970 |
| 16:154083:C:A | P96Q | 0.970 |
| 16:153971:C:G | H59D | 0.969 |
| 16:154396:G:C | R142P | 0.969 |
dbSNP variants (sampled 300 via entrez): RS1000689351 (16:150820 T>G), RS1000741228 (16:151018 T>C), RS1001607930 (16:151756 C>G), RS1001995715 (16:154386 G>A,C,T), RS1002031558 (16:153223 GAGGACAGATAGCGTTCCCTCTCAGTGAGGAGAGCAGGGTA>G), RS1002060106 (16:152058 A>C,T), RS1002344905 (16:153142 G>A,T), RS1005617977 (16:152533 T>C), RS1006023332 (16:152456 G>C), RS1006102427 (16:151329 A>G), RS1006211552 (16:151583 C>G,T), RS1006675968 (16:151440 T>A), RS1007102327 (16:152005 G>A), RS1007785549 (16:154993 A>G), RS1008158580 (16:151315 G>C)
Disease associations
OMIM: gene MIM:142310 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
14 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003122_1 | Hemoglobin levels | 6.000000e-18 |
| GCST004602_219 | Mean corpuscular volume | 8.000000e-15 |
| GCST004630_167 | Mean corpuscular hemoglobin | 1.000000e-33 |
| GCST005951_12 | Body mass index | 5.000000e-11 |
| GCST005992_20 | Mean corpuscular hemoglobin concentration | 7.000000e-30 |
| GCST005993_12 | Mean corpuscular hemoglobin | 2.000000e-78 |
| GCST005996_2 | Red blood cell count | 2.000000e-12 |
| GCST006011_44 | Mean corpuscular volume | 5.000000e-55 |
| GCST006585_1712 | Blood protein levels | 2.000000e-10 |
| GCST008991_6 | Early cardiac repolarization | 1.000000e-06 |
| GCST90002384_352 | Hemoglobin | 2.000000e-12 |
| GCST90002390_626 | Mean corpuscular hemoglobin | 6.000000e-17 |
| GCST90002403_655 | Red blood cell count | 1.000000e-22 |
| GCST90002403_656 | Red blood cell count | 1.000000e-17 |
EFO canonical traits (7, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0007629 | hemoglobin A1 measurement |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0004340 | body mass index |
| EFO:0004528 | mean corpuscular hemoglobin concentration |
| EFO:0004305 | erythrocyte count |
| EFO:0004885 | early cardiac repolarization measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6066981 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.28 | Kd | 522.1 | nM | CHEMBL5653589 |
| 6.28 | ED50 | 522.1 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2148490: Binding affinity to human HBZ incubated for 45 mins by Kinobead based pull down assay | kd | 0.5221 | uM |
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, increases methylation, affects cotreatment | 2 |
| 2,4,6-tribromophenol | decreases expression | 1 |
| decabromobiphenyl ether | decreases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| thrombin receptor-activating peptide SFLLRNPNDKY | increases secretion | 1 |
| entinostat | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
| Hydralazine | affects cotreatment, decreases expression | 1 |
| Hydrogen Peroxide | decreases expression, increases expression | 1 |
| T-2 Toxin | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Butyric Acid | increases expression | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5651532 | Binding | Binding affinity to human HBZ incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.